Results showed that the deletion of a protein, OpgH, in a model bacterium, Caulobacter crescentus, sets off an event cascade that ultimately splits apart the protective, bubble-like cell envelope, eventually killing the cell.
Healthcare & Pharmaceuticals
Six out of eleven nonhuman primates who received an inoculation against the 1918 flu virus, which was prevalent a century ago, reportedly withstood exposure to H5N1, one of the worst viruses now circulating in the globe. On the other hand, six uninfected monkeys in the control group that were infected with the H5N1 virus died from the illness.
This new study offers a broadly useful technique to improve nanobodies’ performance. Artificially created antibody fragments, known as nanobodies, are around 10 times smaller than regular antibodies.
Researchers at Scripps Research have recently discovered that when taken with checkpoint inhibitors, the immunosuppressive medication ruxolitinib, which is licenced, enhanced T-cell responses and increased the drugs’ ability to fight cancer.
This research appears to be the first to investigate the relationship between gut microbiota, brain function, and resilience.
Despite being influenced by prior vaccinations, the new vaccine produces widely neutralizing antibodies in response.
Research establishes foundation for clinical experiment targeted at averting brain tumours in kids with NF1.
mRNA vaccines are thought to be revolutionary. In addition to being utilized to combat the COVID-19 pandemic, they are also being considered for the treatment of several malignancies
Casgevy, one of these treatments, is the first FDA-approved medication to make use of a revolutionary form of genome editing technique
Researchers identified an allergy pathway, which can produce antitumor immunity.
